{"id":{"repo_id":"loma-linda","oai_identifier":"oai:scholarsrepository.llu.edu:etd-1041"},"canonical_url":"https://search.dev.ndltd.org/etd/loma-linda/oai:scholarsrepository.llu.edu:etd-1041","repository":{"repo_id":"loma-linda","name":"Loma Linda University","base_url":"https://scholarsrepository.llu.edu/do/oai/"},"display":{"title":"Nanomaterials and Block Copolymers for Overcoming Multidrug Resistance in Cancer","abstract":"The development of multidrug resistance in cancer is one of the leading causes for decreased chemotherapy efficacy and is particularly threatening to aggressive cancers such as that of the pancreas. In cancers where chemotherapy is amongst the few treatment options, it is crucial to develop chemotherapeutics that either bypass or control the development of multidrug resistance. Polymeric nanomaterials such as Pluronics® are of current interest due to their ability to perform these functions in addition to enhancing pro-apoptotic mechanisms. Using the respectively known chemosensitive and chemoresistant pancreatic adenocarcinoma cell lines MiaPaCa-2 and PANC-1, an in vitro analysis of the synergistic effect using 5-fluorouracil in conjugation with Pluronic® F127 was performed. By monitoring cell viability and regulation of cell cycle, we were able to show that compared to the use of 5-flurouracil alone, there was enhanced cytotoxicity when using drug associated with Pluronic® F127 in MiaPaCa-2 cells. The more chemoresistant cell line PANC-1 showed no significant enhancement of 5-fluorouracil cytotoxicity when associated with Pluronic® F127. Enhanced cytotoxicity due to the use of Pluronic® F127 may potentially become an exploitable feature for novel chemotherapeutic development in the future.","abstract_html":"The development of multidrug resistance in cancer is one of the leading causes for decreased chemotherapy efficacy and is particularly threatening to aggressive cancers such as that of the pancreas. In cancers where chemotherapy is amongst the few treatment options, it is crucial to develop chemotherapeutics that either bypass or control the development of multidrug resistance. Polymeric nanomaterials such as Pluronics® are of current interest due to their ability to perform these functions in addition to enhancing pro-apoptotic mechanisms. Using the respectively known chemosensitive and chemoresistant pancreatic adenocarcinoma cell lines MiaPaCa-2 and PANC-1, an in vitro analysis of the synergistic effect using 5-fluorouracil in conjugation with Pluronic® F127 was performed. By monitoring cell viability and regulation of cell cycle, we were able to show that compared to the use of 5-flurouracil alone, there was enhanced cytotoxicity when using drug associated with Pluronic® F127 in MiaPaCa-2 cells. The more chemoresistant cell line PANC-1 showed no significant enhancement of 5-fluorouracil cytotoxicity when associated with Pluronic® F127. Enhanced cytotoxicity due to the use of Pluronic® F127 may potentially become an exploitable feature for novel chemotherapeutic development in the future.","abstract_has_math":false,"creators":["Livingstone, Wesley"],"institution":null,"degree_name":"Master of Science (MS)","degree_level":"Thesis","degree_discipline":"Basic Sciences","degree_department":null,"school":null,"contributors":["Perry, Christopher"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2011,"date_issued":"2011-06-01T07:00:00Z","date_published":"2011-06-01T07:00:00Z","updated_at":"2026-07-24T02:52:08Z","subjects":["Medical Biochemistry","Neoplasms -- Drug therapy;","Nanomaterials","Multidrug Resistance","Chemotherapy","Cancer"],"languages":["English"],"rights":["This title appears here courtesy of the author, who has granted Loma Linda University a limited, non-exclusive right to make this publication available to the public. The author retains all other copyrights."],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://scholarsrepository.llu.edu/etd/42","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Perry, Christopher"]},{"key":"dc:creator","label":"Author","values":["Livingstone, Wesley"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"thesis:degree_discipline","label":"Discipline","values":["Basic Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (MS)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medical Biochemistry","Neoplasms -- Drug therapy;","Nanomaterials","Multidrug Resistance","Chemotherapy","Cancer"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]},{"key":"dc:rights","label":"Dc Rights","values":["This title appears here courtesy of the author, who has granted Loma Linda University a limited, non-exclusive right to make this publication available to the public. The author retains all other copyrights."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://scholarsrepository.llu.edu/etd/42"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The development of multidrug resistance in cancer is one of the leading causes for decreased chemotherapy efficacy and is particularly threatening to aggressive cancers such as that of the pancreas. In cancers where chemotherapy is amongst the few treatment options, it is crucial to develop chemotherapeutics that either bypass or control the development of multidrug resistance. Polymeric nanomaterials such as Pluronics® are of current interest due to their ability to perform these functions in addition to enhancing pro-apoptotic mechanisms. Using the respectively known chemosensitive and chemoresistant pancreatic adenocarcinoma cell lines MiaPaCa-2 and PANC-1, an in vitro analysis of the synergistic effect using 5-fluorouracil in conjugation with Pluronic® F127 was performed. By monitoring cell viability and regulation of cell cycle, we were able to show that compared to the use of 5-flurouracil alone, there was enhanced cytotoxicity when using drug associated with Pluronic® F127 in MiaPaCa-2 cells. The more chemoresistant cell line PANC-1 showed no significant enhancement of 5-fluorouracil cytotoxicity when associated with Pluronic® F127. Enhanced cytotoxicity due to the use of Pluronic® F127 may potentially become an exploitable feature for novel chemotherapeutic development in the future."]},{"key":"dc:title","label":"Title","values":["Nanomaterials and Block Copolymers for Overcoming Multidrug Resistance in Cancer"]}]}],"canonical_facts":{"dc:contributor":["Perry, Christopher"],"dc:creator":["Livingstone, Wesley"],"dc:description.abstract":["The development of multidrug resistance in cancer is one of the leading causes for decreased chemotherapy efficacy and is particularly threatening to aggressive cancers such as that of the pancreas. In cancers where chemotherapy is amongst the few treatment options, it is crucial to develop chemotherapeutics that either bypass or control the development of multidrug resistance. Polymeric nanomaterials such as Pluronics® are of current interest due to their ability to perform these functions in addition to enhancing pro-apoptotic mechanisms. Using the respectively known chemosensitive and chemoresistant pancreatic adenocarcinoma cell lines MiaPaCa-2 and PANC-1, an in vitro analysis of the synergistic effect using 5-fluorouracil in conjugation with Pluronic® F127 was performed. By monitoring cell viability and regulation of cell cycle, we were able to show that compared to the use of 5-flurouracil alone, there was enhanced cytotoxicity when using drug associated with Pluronic® F127 in MiaPaCa-2 cells. The more chemoresistant cell line PANC-1 showed no significant enhancement of 5-fluorouracil cytotoxicity when associated with Pluronic® F127. Enhanced cytotoxicity due to the use of Pluronic® F127 may potentially become an exploitable feature for novel chemotherapeutic development in the future."],"dc:identifier":["https://scholarsrepository.llu.edu/etd/42"],"dc:language":["English"],"dc:rights":["This title appears here courtesy of the author, who has granted Loma Linda University a limited, non-exclusive right to make this publication available to the public. The author retains all other copyrights."],"dc:subject":["Medical Biochemistry","Neoplasms -- Drug therapy;","Nanomaterials","Multidrug Resistance","Chemotherapy","Cancer"],"dc:title":["Nanomaterials and Block Copolymers for Overcoming Multidrug Resistance in Cancer"],"thesis:degree_discipline":["Basic Sciences"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Master of Science (MS)"]},"updated_at":"2026-07-24T02:52:08Z"}